{"task_id": "7b84c6fd6a9a0487", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 53/464)", "text": "ase transport system. This\n38\nDigoxin Intoxication\n\n--- Page 60 ---\nPATHOPHYSIOLOGY (CONT\u2019D)\nleads to intracellular loss of K and gain of Na. Increase\nin intracellular Ca leads to \" cardiac contractility.\nDigoxin also exerts a vagotonic action, which slows\nconduction through the SA and AV node and helps to\ncontrol heart rate\nPRECIPITANTS OF DIGOXIN TOXICITY\ntoxicity is\nnot merely related to serum levels, but also digoxin\ndosing (e.g. acute overdose), other medications (e.g.\nnon potassium sparing diuretics), and conditions (e.g.\nrenal insufficiency, acute coronary syndromes, cardiac\namyloidosis, hypothyroidism). For instance, hypokale\nmia, hypernatremia, hypomagnesemia and acidosis\npredispose to toxicity even at low serum digoxin levels\nbecause of their depressive effects on the Na/K ATPase\npump. In contrast, hyperkalemia occurs in acute toxicity\nand is directly related to prognosis\nCLINICAL FEATURES\nSIGNS AND SYMPTOMS\n\u0002\nNEUROLOGICAL\ndelirium,\nhallucination,\nblurred\nvision with altered color perception, headaches,\ndizziness\n\u0002\nCARDIAC\nbradycardia, high degree AV block, par\noxysmal atrial tachycardia, unifocal or multifocal\nPVCs, bidirectional ventricular tachycardia, accel\nerated junctional tachycardia\n\u0002 GI\nanorexia, N&V, diarrhea, abdominal pain\n\u0002\nMETABOLIC\nhyperkalemia\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, Ca, Mg, albumin,\nserum digoxin level\n\u0002 ECG\n\u0002 ABG\nDIAGNOSTIC ISSUES\nECG CHANGES ASSOCIATED WITH DIGOXIN\n\u0002\nTHERAPEUTIC LEVELS\nsagging of ST segments, flat\ntened T waves, U waves, and shortened QT. Not to\nbe confused with digoxin toxicity\nDIAGNOSTIC ISSUES (CONT\u2019D)\n\u0002\nTOXIC LEVELS\nfirst degree heart block, paroxysmal\natrial tachycardia, regularized atrial fibrillation, uni\nfocal or multifocal PVCs, ventricular bigeminy,\nbidirectional VT\nMANAGEMENT\nACUTE\nABC, O2, IV, treat arrhythmia\nTREAT UNDERLYING CAUSE\nobserve, cardiac\nmonitoring, activated charcoal (if ingestion within\n4 h). Correct electrolyte disturbances and reverse\nacidosis. Atropine for bradycardia. Digibind/puri\nfied antidigoxin FAB fragments (if ingested\n10 mg of more in adults, or digoxin level >13 nmol/L\n[10 ng/mL], K >5 mM and life threatening arrhythmia,\nhemodynamic instability or severe bradycardia. May see\nresponse in 20 min and complete response up to 4 h.\nMonitor potassium levels after treatment with Digibind)\nTREATMENT ISSUES\nAVOID\n\u0002 IV CALCIUM\nindicated for other causes of severe\nhyperkalemia, calcium may precipitate VT/sudden\ndeath and should NOT be given for hyperkalemia\nof digoxin toxicity\n\u0002\nCARDIOVERSION\nrelatively contraindicated because\nasystole or ventricular fibrillation may be precipitated\n\u0002\nTRANSVENOUS PACING\ncan precipitate arrhythmias\nand deterioration\nHALF LIVES\nplasma t\u00bd for digoxin 1.6 days, digi\ntoxin 5 days\nINDICATIONS FOR DIGOXIN THERAPY\nin patients\nwith symptomatic systolic HF and sinus rhythm\n(digoxin may be especially useful in patients with\nsevere symptoms despite standard medical therapy,\nLVEF <25%, or cardiomegaly), diastolic HF (with\nrapid atrial fibrillation or severe symptoms despite\nstandard medical therapy), and rapid atrial fibrilla\ntion (with or without heart failure). Use with extreme\ncaution or avoid in the elderly, patients with severe\nconduction abnormalities, acute coronary syndromes,\nor renal failure\nAtrial Fibrillation\nNEJM 2001 344:14; NEJM 2004 351:23\nDIFFERENTIAL DIAGNOSIS OF PALPITATIONS\nwPPPw\nPHYSIOLOGIC\n(high\noutput\nstates)\nanemia,\npregnancy, fever, exercise, stress\nPATHOLOGIC wCDEw\n\u0002 CARDIAC\narrhythmia (see tachycardia below),\nmyocardial (cardiomyopathy, atrial myxoma,\nshunts), valvular, transplanted heart\nDIFFERENTIAL DIAGNOSIS OF PALPITATIONS\n(CONT\u2019D)\n\u0002 DRUGS\nsympathomimetic agents, vasodilators,\nanticholinergic agents, b blocker withdrawal,\nillicit (cocaine, amphetamines)\n\u0002 ENDOCRINE\nhypoglycemia,\nhyperthyroidism,\npheochromocytoma\nPSYCHIATRIC\npanic attack/disorder, generalized\nanxiety disorder, somatization\nAtrial Fibrillation\n39", "text_length": 3930, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 53/464)", "type": "chunk", "chunk_index": 52, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.305921", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.306736", "status": "complete", "chunks_added": 3}